LINC01779

Across TCGA pan-cancer cohorts, LINC01779 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC01779’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01779 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01779 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and BLCA are the cancer types where LINC01779 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01779 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−0.186	<.001	11	view →
THCA	All	II,III,IV	−0.203	<.001	9	view →
BLCA	All	All	−0.098	.006	8	view →
LUSC	All	II,III,IV	−0.197	<.001	7	view →
LUAD	All	II,III,IV	−0.190	<.001	7	view →
KIRP	All	All	−0.157	<.001	7	view →
HNSC	All	All	−0.045	.014	7	view →
KICH	Male	All	−0.461	<.001	6	view →
COAD	Female	IV	−0.215	.004	6	view →
UCEC	All	All	−0.188	<.001	6	view →
BRCA	All	II,III,IV	−0.110	<.001	6	view →
PRAD	All	All	−0.139	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC01779–KIRC

Open the KIRC breakdown →